ONIDA, FRANCESCO
ONIDA, FRANCESCO
Dipartimento di Oncologia ed Emato-Oncologia
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
2024 R. Greco, T. Alexander, N. Del Papa, F. Müller, R. Saccardi, F. Sanchez-Guijo, G. Schett, B. Sharrack, J.A. Snowden, K. Tarte, F. Onida, I. Sánchez-Ortega, J. Burman, C. Castilla Llorente, R. Cervera, F. Ciceri, A. Doria, J. Henes, J. Lindsay, A. Mackensen, P.A. Muraro, E. Ricart, M. Rovira, T. Zuckerman, I. Yakoub-Agha, D. Farge
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
2024 F. Onida, N. Gagelmann, Y. Chalandon, G. Kobbe, M. Robin, A. Symeonidis, T.M. de Witte, R.A. Itzykson, M. Jentzsch, U. Platzbecker, V. Santini, G.F. Sanz, C. Scheid, E. Solary, P. Valent, R. Greco, I. Sánchez-Ortega, I. Yakoub-Agha, L. Pleyer
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir
2024 G.A. Papanicolaou, R.K. Avery, C. Cordonnier, R.F. Duarte, S. Haider, J. Maertens, K.S. Peggs, C. Solano, J.H. Young, M. Fournier, R.A. Murray, J. Wu, D.J. Winston, D. Singhal, J. Sasadeusz, J. Maertans, A. Georgala, D. Selleslag, A. Verlinden, T. Kerre, A. De Becker, S. Haider, A. Wright, D. Wu, R. Vrhovac, C. Cordonnier, A. Berceanu, S. Francois, D. Michonneau, A. Huynh, W. Bethge, M. Kaufmann, M. Stelljes, G. Franke, T. Schmitt, L. Müller, M. Ahlgrimm, J. Niederland, P. Tsirigotis, R. Ram, N. Shemtov, T. Rosenvald-Zuckerman, I. Cutini, A. Busca, F. Onida, C. Tecchio, P. Browett, Y.R. Do, S.H. Kim, A. Ho, L.P. Koh, M.L.V. Lopez, J.L. Jimenez, C.F. Coll, R. De la Camara, C. Solano, A. Mussetti, J.C.V. Llamas, P.B. Suñol, M.J. Chacón, R.F. Duarte, M.A.B. Rodríguez, N. Mueller, H. Ozdogu, G. Gurman, A. Bloor, B. Kishore, K.S. Peggs, D. Milojkovic, K. Orchard, A.G. Toth, M. Koh, R.K. Avery, J. Pisano, G. Alangaden, D.J. Winston, G. Papanicolau, B. Gewurz, F.M. Marty, J.H. Young, P. Hagen, R. Reshef, S. Abedin, P. Shaughnessy, L. Gibson, J.T. Shore, C.R. Bachier, J. Yared, M. Malinis
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
2024 C. Gurnari, L. Koster, L. Baaij, M. Heiblig, I. Yakoub-Agha, M. Collin, J. Passweg, C.E. Bulabois, A. Khan, M. Loschi, F. Carnevale-Schianca, E. Crisà, D. Caravelli, J. Kuball, F. Saraceni, A. Olivieri, A. Rambaldi, A.G. Kulasekararaj, P.J. Hayden, M. Badoglio, F. Onida, C. Scheid, F. Franceschini, A. Mekinian, S. Savic, M.T. Voso, J. Drozd-Sokolowska, J.A. Snowden, K. Raj, T. Alexander, M. Robin, R. Greco, D.P. Mclornan
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma
2024 F. Bagnoli, G. Pini, B. Ziccheddu, A. Bonometti, S. Alberti-Violetti, L. Venegoni, G. Isimbaldi, M.C. Da Vià, A. Ferrari, L. Baldini, A. Neri, F. Onida, N. Bolli, E. Berti
Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma
2024 G.A. Croci, L. Appio, C. Cecchetti, S. Tabano, S. Alberti-Violetti, E. Berti, D. Rahal, F. Cavallaro, F. Onida, D. Tomasini, E. Todisco
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
2024 M.Q. Salas, D. Eikema, L. Koster, J. Maertens, J. Passweg, J. Finke, A.E.C. Broers, Y. Koc, N. Kröger, Z.N. Ozkurt, M.J. Pascual-Cascon, U. Platzbecker, G. Van Gorkom, T. Schroeder, J.L. López-Lorenzo, M. Martino, P. Chiusolo, M. Kaufmann, F. Onida, C. Gurnari, C. Scheid, J. Drozd-Sokolowska, K. Raj, M. Robin, D.P. Mclornan
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
2024 G. Avallone, G. Roccuzzo, A. Pileri, C. Agostinelli, C.A. Maronese, C. Aquino, G. Tavoletti, F. Onida, P. Fava, S. Ribero, A.V. Marzano, E. Berti, P. Quaglino, S. Alberti‐violetti
L’infezione da CMV refrattaria nella fase post-trapianto: inquadramento epidemiologico nel contesto italiano, attuale gestione del paziente e unmet need : Refractory CMV infection in post-transplant phase: epidemiological framing in the Italian context, current patient management and unmet needs
2023 M. Morani, F. Baldanti, F. Ciceri, F. Citterio, M. Ferraresso, C. Girmenia, U. Maggiore, M. Martino, F. Onida, L. Potena, F. Vistoli, P. Antonio Grossi
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network
2023 R. Itzykson, V. Santini, S. Thepot, L. Ades, C. Chaffaut, A. Giagounidis, M. Morabito, N. Droin, M. Lübbert, R. Sapena, S. Nimubona, J. Goasguen, E. Wattel, G. Zini, J.M. Torregrosa Diaz, U. Germing, A.M. Pelizzari, S. Park, N. Jaekel, G. Metzgeroth, F. Onida, R. Navarro, A. Patriarca, A. Stamatoullas, K. Götze, M. Puttrich, S. Mossuto, E. Solary, S. Gloaguen, S. Chevret, F. Chermat, U. Platzbecker, P. Fenaux
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
2023 K. Rejeski, M. Subklewe, M. Aljurf, E. Bachy, A. Balduzzi, P. Barba, B. Bruno, R. Benjamin, M.G. Carrabba, C. Chabannon, F. Ciceri, P. Corradini, J. Delgado, R. Di Blasi, R. Greco, R. Houot, G. Iacoboni, U. Jäger, M.J. Kersten, S. Mielke, A. Nagler, F. Onida, Z. Peric, C. Roddie, A. Ruggeri, F. Sánchez-Guijo, I. Sánchez-Ortega, D. Schneidawind, M. Schubert, J.A. Snowden, C. Thieblemont, M. Topp, P.L. Zinzani, J.G. Gribben, C. Bonini, A. Sureda, I. Yakoub-Agha
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
2023 L. Pagano, P.L. Zinzani, S. Pileri, P. Quaglino, B. Cuglievan, E. Berti, N. Pemmaraju, F. Onida, R. Willemze, A. Orfao, G. Barosi
Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience
2023 G. Cassanello, F. Serpenti, F. Bagnoli, G. Saporiti, M. Goldaniga, F. Cavallaro, K. Barbullushi, V. Bellani, G. Galassi, F. Onida
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
2023 M. Malagola, N. Polverelli, M. Martino, F. Patriarca, B. Bruno, L. Giaccone, G. Grillo, S. Bramanti, P. Bernasconi, M. De Gobbi, A. Natale, E. Terruzzi, A. Olivieri, P. Chiusolo, A.M. Carella, M. Casini, E. Maffini, C. Nozzoli, P. Mazza, S. Bassi, F. Onida, A. Vacca, S. Falcioni, M. Luppi, A.P. Iori, V. Pavone, C. Skert, P. Carluccio, C. Borghero, A. Proia, C. Selleri, V. Rubini, N. Sacchi, E. Oldani, F. Bonifazi, F. Ciceri, D. Russo
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy
2023 I. Yakoub-Agha, R. Greco, F. Onida, R. de la Cámara, F. Ciceri, S. Corbacioglu, H. Dolstra, B. Glass, M. Kenyon, D.P. Mclornan, B. Neven, R.P. de Latour, Z. Peric, A. Ruggeri, J.A. Snowden, A. Sureda, I. Sánchez-Ortega
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
2022 F. Onida, G. Sbianchi, A. Radujkovic, K. Sockel, N. Kroger, J. Sierra, G. Socie, J. Cornelissen, X. Poire, L. Raida, J.H. Bourhis, J. Finke, J. Passweg, U. Salmenniemi, H.C. Schouten, Y. Beguin, S. Martin, E. Deconinck, A. Ganser, S. Zver, B. Lioure, R. Rohini, L. Koster, P. Hayden, S. Iacobelli, M. Robin, I. Yakoub-Agha
Natural and assisted conceptions in male cancer recipients of hematopoietic cell transplantation who stored their semen for fertility preservation
2022 M. Reschini, M. Cristina, S. Ferrari, F. Filippi, E. Somigliana, F.G. Rossi, L. Boeri, F. Onida, L. Baldini, P. Vigano'
Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNA
2022 E.M. Rodrigues, G. Ardissino, G. Pintarelli, V. Capone, J. Mariotti, M. Verna, M.E. Bernardo, M. Faraci, M. Tozzi, A. Bucalossi, E. Schiavello, V. Biassoni, A. Guidetti, A. Carotti, L. Facchini, E. Terruzzi, F. Giglio, M. Zecca, F. Onida, L. Caroti, S. Cesaro, D. Consonni, M. Cugno, L. Porcaro
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms
2022 M. Malagola, N. Polverelli, V. Rubini, M. Martino, F. Patriarca, B. Bruno, L. Giaccone, G. Grillo, S. Bramanti, P. Bernasconi, M. De Gobbi, A. Natale, E. Terruzzi, A. Olivieri, P. Chiusolo, A.M. Carella, M. Casini, C. Nozzoli, P. Mazza, S. Bassi, F. Onida, A. Vacca, S. Falcioni, M. Luppi, A.P. Iori, V. Pavone, C. Skert, P. Carluccio, C. Borghero, A. Proia, C. Selleri, N. Sacchi, S. Mammoliti, E. Oldani, F. Ciceri, D. Russo, F. Bonifazi
Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse
2022 F. Serpenti, M. Sciumè, G. Galassi, G. Saporiti, F. Grifoni, N. Rampi, F. Cavallaro, K. Barbullushi, E. Tagliaferri, M. Goldaniga, L. Baldini, N.S. Fracchiolla, F. Onida